Titre:
  • Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.
Auteur:Metzger-Filho, Otto; Procter, Marion; Azambuja, Evandro; Leyland-Jones, Brian; Gelber, Richard D; Dowsett, Mitchell; Loi, Sherene; Saini, Kamal S; Cameron, David A; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, José; Jackisch, Christian; Bell, Richard H; Sotiriou, Christos; Viale, Giuseppe; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 31, 16, page (1954-1960)
Statut de publication:Publié, 2013-06
Sujet CREF:Cancérologie
Sciences biomédicales
MeSH keywords:Adult
Aged
Antibodies, Monoclonal, Humanized -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- chemistry -- drug therapy -- pathology
Carcinoma, Ductal, Breast -- chemistry -- drug therapy -- pathology
Carcinoma, Lobular -- chemistry -- drug therapy -- pathology
Disease-Free Survival
Female
Follow-Up Studies
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphatic Metastasis
Middle Aged
Neoplasm Invasiveness
Proportional Hazards Models
Receptor, ErbB-2 -- analysis
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Survival Analysis
Treatment Outcome
Tumor Markers, Biological -- analysis
Note générale:Journal Article
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2012.46.2440
info:pii/JCO.2012.46.2440
info:scp/84880681360
info:pmid/23589556